Evaluation of effects of cardamom supplementation among obese women with polycystic ovary syndrome

Phase 3

• Conditions: Poly-cystic Ovarian Syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20200608047697N1
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

Diagnosis of polycystic ovary syndrome based on Rotterdam criteria for at least two of the following factors: 1. Oligomnorrhea or amenorrhea. 2. Biochemical or clinical symptoms increased levels of androgens in the blood.3- Having polycystic ovaries in ultrasound
Women with age range between 18-45 year
Body mass index more than 30 kg/m2
Voluntary participation in the project

Exclusion Criteria

Pregnancy and lactation
Illnesses such as autoimmune, gastrointestinal, liver, thyroid and unstable cardiovascular diseases, severe depression, mental diseases, severe respiratory diseases (asthma and chronic bronchitis)
Take any vitamin and mineral supplements
Allergies to cardamom, cardamom tea and cardamom products

Study & Design

• Study Type: interventional
• Study Design: Not specified